GlassScriptPhysician profile
Jeffrey L Young
NPI 1225008220
$2,857.56
in general payments reported to CMS, 2019-2025
15 companies · $611 in 2025
The $611 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $55.09 · 2021: $379 · 2022: $565 · 2023: $471 · 2024: $606 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,528 · Gift: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,528.23 |
| Gift | $159.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,662.25 | 2019-2025 | Rinvoq, Skyrizi, Viberzi |
| Braintree Laboratories, INC. | $452.54 | 2019-2023 | Sutab |
| Pfizer INC. | $373.37 | 2019-2025 | |
| Celgene Corporation | $60.41 | 2022-2024 | Zeposia |
| Mauna Kea Technologies, INC. | $45.61 | 2021 | |
| Ardelyx, INC. | $42.57 | 2024-2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $36.11 | 2019-2025 | Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.54 | 2019-2024 | Trulance |
| Phathom Pharmaceuticals, INC. | $29.66 | 2024-2025 | Voquezna |
| Micro-Tech Endoscopy USA, INC. | $28.79 | 2022-2025 | Riteclip |
| Genzyme Corporation | $23.09 | 2024 | |
| Allergan, INC. | $19.56 | 2019 | |
| Cook Medical LLC | $18.10 | 2022 | |
| Celltrion USA INC. | $16.92 | 2024 | Vegzelma |
| Ironwood Pharmaceuticals, INC | $13.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.